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Comment on “Influence of HLA-C
Expression Level on HIV Control”
Elisa Lo Monaco,1 Elisa Tremante,1 Priscilla Biswas,2 Martin P. Cranage,3 Donato Zipeto,4
Alberto Beretta,2 Patrizio Giacomini1*
Apps et al. (Reports, 5 April 2013, p. 87) found that high human leukocyte antigen C (HLA-C)
expression favors HIV-1 control. However, as noted here, HLA-C was assessed with a monoclonal
antibody (DT9) that cross-reacts with HLA-E. In the context of the available evidence, this is
consistent with the idea that the two leukocyte antigens collaborate to keep the HIV-1 virus at bay.
Areport recently published in Science dem-onstrated that the control of HIV-1 infec-tion is positively influenced by high human
leukocyte antigen C (HLA-C) expression (1). We
note that this observation largely relies on ex-
tensive flow cytometry testing with amonoclonal
antibody (mAb) namedDT9, and draw attention to
the original paper inwhich thismAbwas described
to primarily bind HLA-E, HLA-C being second-
arily detected as a result of cross-reactivity (2).
The claim byApps et al. for operationalHLA-C
specificity of mAb DT9 is based on extensive
background information previously presented by
the same group, particularly the lack of coex-
pressed HLA-E on the surface of human periph-
eral bloodmononuclear cells (PBMCs), as assessed
by a mAb named MEM-E/08 (3). However, this
finding has subsequently been challenged by
Corrah et al., whohave instead documentedPBMC
stainingwith anothermAb toHLA-E, called 3D12
(4). Further adding to this controversy, and in
agreement with Corrah et al., we have shown that
mAb MEM-E/08 reacts with poorly expressed,
unstable, unfolded HLA-E molecules free of their
light chain subunit (b2m). In addition, we found
that HLA-E levels are often underestimated, be-
cause a fraction of HLA-E is surface-expressed
as a tightly b2m-associated conformer poorly re-
active with the available mAbs, including to some
extent even the conformational mAb 3D12 (5).
Altogether, these results favor the possibility that
HLA-E substantially contributes to DT9 reac-
tivity on the surface of many different human
cells. HLA-E cross-reactivity, even marginal, may
not be negligible in this setting, since HLA-C is
the lowest expressed classical class I molecule
[reviewed in (6)].
On this basis, we suggest that mAb DT9 de-
tects combined HLA-C/HLA-E expression and
that this combination, rather than HLA-C alone,
may be considered the most accurate readout for
the outcome of HIV-1 infection. Essentially all
the HLA-C alleles, but only some HLA-A and
HLA-B alleles, encode signal sequences poten-
tially acting as donors of stabilizing HLA-E lig-
ands (7, 8) (also see www.ebi.ac.uk/ipd/imgt/hla),
providing direct insight into linked, and possibly
coordinated, expression of HLA-C and HLA-E
(Fig. 1). Coordination would result in HLA-E sim-
ilarly contributing to DT9 binding in different
HLA-C–expressing cells. Thus, HLA-E cross-
reactivity would not preclude the discrimination
of HLA-C–high from HLA-C–low alleles, a dis-
crimination that is central to the HIV protection
model put forward in several papers by the au-
thors of (1). Protection from, and susceptibility
to, HIV infection may then be interpreted in the
context of a compound multilocus effect.
This alternative interpretation does not con-
tradict, but rather complements, the original in-
terpretation of Apps et al. (1). HighHLA-Cwould
incite cytotoxic Tcell recognition, exactly as out-
lined by these authors, whereas high HLA-Emay
be instrumental in directing the lysis of virus-
infected cells by certain HLA-E–restricted T cell
subsets, as shown in the case of cytomegalovirus
(9). Alternatively, or in addition, inhibitory HLA-E
may engender a tolerogenic effect that paradox-
ically prevents the establishment of productive
viral infection, as described in a macaque model
of simian immunodeficiency virus vaccination (10).
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Fig. 1. HLA-C and HLA-E: linked expression,
reactivity with mAb DT9, and possible collab-
orative protection from HIV-1. Two patterns of
mAb DT9 reactivity are depicted, implying dif-
ferent HIV-1 control models. The first (A), proposed
by Apps et al., is based on a restricted HLA-C re-
activity of DT9 and is consistent with demonstrated,
HLA-C–specific protective effects (1, 11). The sec-
ond (B), hypothesized here on the basis of the
previously observed HLA-E cross-reactivity with DT9,
envisages a compound multilocus effect. Because
HLA-E requires peptides donated from the signal
sequence of HLA-C for its stable assembly with
b2m, we suggest that the two class I HLA molecules
are coordinately expressed: The higher HLA-C is,
the higher is the surface HLA-E pool. Because they
are expressed in proportional amounts, HLA-E does
not prevent the appreciation of differences in HLA-
C expression by mAb DT9. Evidence for a protective
role of HLA-E remains so far indirect.
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